U.S. markets close in 4 hours 39 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
40.38+0.37 (+0.91%)
As of 11:21AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close40.01
Bid40.41 x 1800
Ask40.42 x 2900
Day's Range40.13 - 40.50
52 Week Range39.23 - 56.32
Avg. Volume22,962,442
Market Cap227.893B
Beta (5Y Monthly)0.59
PE Ratio (TTM)7.41
EPS (TTM)5.45
Earnings DateMay 02, 2023
Forward Dividend & Yield1.64 (4.02%)
Ex-Dividend DateJan 26, 2023
1y Target Est50.97
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more